RT Journal Article
SR Electronic
T1 Covid-19 rapid test by combining a random forest based web system and blood tests
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.12.20129866
DO 10.1101/2020.06.12.20129866
A1 Valter Augusto de Freitas Barbosa
A1 Juliana Carneiro Gomes
A1 Maíra Araújo de Santana
A1 Clarisse Lins de Lima
A1 Raquel Bezerra Calado
A1 Claúdio Roberto Bertoldo Júnior
A1 Jeniffer Emidio de Almeida Albuquerque
A1 Rodrigo Gomes de Souza
A1 Ricardo Juarez Escorel de Araújo
A1 Ricardo Emmanuel de Souza
A1 Wellington Pinheiro dos Santos
YR 2020
UL http://medrxiv.org/content/early/2020/06/16/2020.06.12.20129866.abstract
AB Background The disease caused by the new type of coronavirus, the Covid-19, has posed major public health challenges for many countries. With its rapid spread, since the beginning of the outbreak in December 2019, the disease transmitted by SARS-Cov2 has already caused over 400 thousand deaths to date. The diagnosis of the disease has an important role in combating Covid-19.Objective In this work, we propose a web system, Heg.IA, which seeks to optimize the diagnosis of Covid-19 through the use of artificial intelligence.Method The main ideia is that healthcare professionals can insert 41 hematological parameters from common blood tests and arterial gasometry into the system. Then, Heg.IA will provide a diagnostic report. It will indicate if the patient is infected with SARS-Cov2 virus, and also predict the type of hospitalization (regular ward, semi-ICU, or ICU).Results We developed a web system called Heg.IA to support decision-making regarding to diagnosis of Covid-19 and to the indication of hospitalization on regular ward, semi-ICU or ICU. This application is based on decision trees in a Random Forest architecture with 90 trees. The system showed to be highly efficient, with great results for both Covid-19 diagnosis and to recommend hospitalization. For the first scenario we found average results of accuracy of 92.891% ± 0.851, kappa index of 0.858 ± 0.017, sensitivity of 0.936 ± 0.011, precision of 0.923 ± 0.011, specificity of 0.921 ± 0.012 and area under ROC of 0.984 ± 0.003. As for the indication of hospitalization, we achieved excellent performance of accuracies above 99% and more than 0.99 for the other metrics in all situations.Conclusion By using a computationally simple method, based on the classical decision trees, we were able to achieve high diagnosis performance. Heg.IA system may be a way to overcome the testing unavailability in the context of Covid-19. We also expect the system will provide wide access to Covid-19 effective diagnosis and thereby reach and help saving lives.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors are grateful to the Federal University of Pernambuco, Google Cloud COVID-19 Research Grant, and the Brazilian research agencies CAPES and CNPq, for the partial financial support of this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available under requirement.